About this trial
Approximately 300,000 Hispanic individuals experience respiratory failure each year in the U.S. Hispanic patients are twice as likely to die from respiratory failure as non-Hispanic patients. There is an urgent need to identify and remediate mechanisms that increase risk of death from respiratory failure. The team's preliminary work identified two potential mechanisms: Hispanic patients with respiratory failure are more likely to be deeply sedated and less likely to receive physical therapy than non-Hispanic patients, which are both associated with mortality and poor long-term functional outcomes. The overall objective of this proposal is to improve outcomes for patients with respiratory failure through changes in intensive care unit (ICU) practice. This trial will refine and pilot an intervention to promote guideline-concordant care. The team's preliminary intervention will be iteratively refined through patient, family, and clinician engagement and piloted at two U.S. ICUs. The outcome of this study will be an intervention aimed at reducing mortality from respiratory failure.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
We will include physicians, nurses, and other staff at participating ICUs who consent to participate.
Disqualifiers
We will exclude potential participants who cannot speak either English or Spanish.
Trial design
Single group
Treatments tested in this trial
Safer sedation bundle
Other interventionThis is a unit-level quality improvement intervention to facilitate evidence-based sedation delivery. The quality improvement intervention consists of identification of a safe sedation champion among clinical staff, initiation of sedation rounds, and tools to facilitate structured assessment of sedation depth, delirium, and pain.
Treatment groups
Trial outcomes
Primary outcomes
Feasibility and acceptability
The co-primary endpoints are acceptability and feasibility. We will measure acceptability and feasibility in surveys using construct definitions from the Consolidated Framework for Implementation Research (CFIR) .
Secondary outcomes
Patient safety culture score
Measured using AHRQ's Survey on Patient Safety Culture.
Other outcomes
Implementation barriers and facilitators
Measured using the 14-item pCAT brief quantitative assessment from the CFIR.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
New York University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: